Goldman Sachs lifts Danaher Corp stock target to USD 275.00

Published on 10/26/2026 at 16:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Twenty-four analysts set a USD 242.91 consensus target. Danaher stock costs EUR 208.50 on October 26, 2026, 0.80 percent above the Frankfurt close.

Analyst target and reporting date

Goldman Sachs lifted its Danaher target from USD 250.00 to USD 275.00 on October 22, 2026.
Twenty-four analysts set a USD 242.91 consensus target.
Danaher stock costs EUR 208.50 at Lang & Schwarz on October 26, 2026 at 4:30 p.m. CEST, 0.80 percent above the Frankfurt close.
Third-quarter revenue reached USD 6.60 billion, up 8.50 percent year over year.

Danaher Corp., US2358511028, Illustration mit AI erstellt.

Danaher Corp. (ISIN US2358511028) attracted a higher Goldman Sachs target of USD 275.00, up from USD 250.00 in the firm's October 22, 2026 note, according to MarketScreener. Danaher stock was trading at EUR 208.50 at Lang & Schwarz on October 26, 2026 at 4:30 p.m. CEST, 0.80 percent above the Frankfurt close of EUR 206.85 from October 23, 2026.

Analysts lift the valuation bar

Goldman Sachs was part of a broad round of target changes after Danaher's third-quarter report. MarketScreener listed a USD 275.00 target for Goldman Sachs, while the article also recorded USD 270.00 targets from JPMorgan and Citigroup and a USD 260.00 target from Barclays on October 22, 2026. The USD 275.00 target stands 18.04 percent above the USD 232.96 NYSE price at 11:32 a.m. EDT on October 26, 2026.

MarketBeat counted 24 analysts and put the consensus target at USD 242.91 on October 26, 2026. That consensus is 4.27 percent above the NYSE price, while the Goldman Sachs target is materially higher, leaving the target range as the clearest valuation signal for the stock.

Stock sits below its yearly high

Danaher traded at USD 232.96 on the NYSE at 11:32 a.m. EDT on October 26, 2026, with 845,235 shares changing hands. The 52-week range was USD 160.93 to USD 242.80, putting the price 4.05 percent below the high and 44.76 percent above the low.

The company had a market capitalization of USD 163.8 billion on October 26, 2026. Its price-to-earnings ratio was 38.15, while the 2026 third-quarter report listed USD 6.60 billion in revenue, up 8.50 percent from the comparable period. Danaher also reported USD 1.20 billion in net earnings and adjusted diluted earnings per share of USD 2.11 for the quarter, according to Danaher.

Cash flow adds a second support

The same report dated October 21, 2026 recorded USD 1.89 billion in operating cash flow and USD 1.63 billion in non-GAAP free cash flow for the third quarter. Those figures provide a separate operating measure alongside the revenue growth and the analyst revisions.

Danaher operates across biotechnology, diagnostics and life sciences. The company reported 60,000 associates in its October 21 release, while respiratory testing remained a specific factor in its fourth-quarter outlook.

Investor view at EUR 208.50

The combination of a USD 275.00 high target and a USD 242.91 consensus target places valuation expectations above the NYSE price, while the euro quote remains below the October 23 Frankfurt close by venue comparison only through its current Lang & Schwarz premium. The next key reference for investors is how the reported revenue growth translates into sustained core expansion.

Danaher stock was trading at EUR 208.50 at Lang & Schwarz on October 26, 2026 at 4:30 p.m. CEST, 0.80 percent above the Frankfurt close of October 23, 2026 at EUR 206.85. The further course of trading is shown by the continuously updated real-time quote of Danaher Corp stock.